S14-258 Using Bispecific Antibodies to Target Cancer Cells for Phagocytic Removal Stanford scientists have discovered that bispecific antibodies can selectively bind cancer cells and block the CD47-SIRPα "don't eat me signal" to efficiently clear tumors with negligible toxicity. Ravindra Majeti Emily Piccione Griffin